FUELCELL ENERGY INC 8-K

What Happened

• FuelCell Energy, Inc. (FCEL) filed an 8-K reporting that it ended the employment of Joshua Dolger, Executive Vice President, General Counsel and Corporate Secretary, without cause effective January 6, 2026. The company expects to negotiate a separation agreement with Dolger, with material terms not yet finalized.
• The Board appointed Amanda J. Schreiber as Executive Vice President, General Counsel and Corporate Secretary, effective January 12, 2026. The company entered into an employment agreement with Ms. Schreiber on January 6, 2026.

Key Details

• Joshua Dolger’s employment terminated without cause effective January 6, 2026; separation agreement terms to be disclosed if finalized.
• Amanda Schreiber’s employment terms: annual base salary $470,000 and target annual bonus equal to 60% of base salary.
• Long-term incentive target for 2026: $750,000 (expected to be 50% performance share units with a three-year cliff vest and 50% time-vesting RSUs).
• Severance: if terminated without cause or for good reason, Schreiber receives 12 months’ base salary plus up to 12 months COBRA premiums; change-in-control termination provides one year’s base salary plus one year’s average (or target) bonus, COBRA up to 12 months, and equity acceleration in certain change-in-control terminations.
• The Employment Agreement with Ms. Schreiber is filed as Exhibit 10.1 to the Form 8-K.

Why It Matters

• This is a material executive change in the company’s legal leadership; investors should note continuity in senior legal oversight with a seasoned hire from ContourGlobal.
• Potential separation or severance payments (Dolger’s separation agreement and any equity/severance triggers) may affect near-term operating expenses; the company has not yet disclosed amounts for Dolger.
• Ms. Schreiber’s pay and robust severance/change-in-control protections are disclosed and could lead to future compensation expense or equity vesting if triggered; monitor future filings for the finalized separation agreement and any related charges or equity grants.